Skip to main content.

Aaron J. Katz, Pharm.D., P.h.D.

Aaron Katz portrait
Research Assistant Professor, Population Health

Professional Background

Dr. Katz is a pharmacist, pharmacoepidemiologist, and health services researcher. His formal research training includes a doctoral degree from the University of North Carolina at Chapel Hill, Eshelman School of Pharmacy, Division of Pharmaceutical Outcomes and Policy. He has a strong background in epidemiologic and observational research methods that he leverages to conduct population-based cancer research, with specific applications and expertise in treatment utilization and comparative effectiveness studies.

Education and Training
  • BS, Psychology, University of South Dakota, Vermillion, SD
  • PharmD, Pharmacy, Midwestern University, College of Pharmacy - Glendale, Glendale, AZ
  • PhD, Pharmaceutical Sciences, University of North Carolina at Chapel Hill, Chapel Hill, NC
Licensure, Accreditations & Certifications
  • Pharmacist, North Carolina Board of Pharmacy
Professional Affiliations
  • AcademyHealth, Member, 2021 - Present
  • International Society for Pharmacoepidemiolgy, Member, 2009 - Present



Dr. Katz has expertise in the design and execution of observational research, hands-on facilitation of data linkage from disparate data sources (e.g., cancer registry, patient-reported surveys, administrative claims, electronic health records, and clinical research datasets), and analysis of linked datasets to evaluate the utilization, comparative effects, and resultant costs of care.

Dr. Katz has broad research interests in understanding the comparative effectiveness of therapies, identifying and addressing underlying causes of disparities in access to and receipt of guideline-recommended care, and developing solutions to improve processes of care and treatment decisions - all with the underlying goal of improving humanistic and clinical outcomes for patients.

  • Katz, Aaron., J, Haynes, Kevin, Du, Simo, Barron, John, Kubik, Rhyan, Chen, Ronald., C. 2022. Evaluation of Telemedicine Use Among US Patients With Newly Diagnosed Cancer by Socioeconomic Status. JAMA Oncology, 8 (1), 161-163
  • Chen, Ronald., C, Haynes, Kevin, Simo, Barron, John, Katz, Aaron., J. 2021. Association of cancer screening deficit in the United States with the COVID-19 pandemic. JAMA Oncology, 7 (6), 878-884
  • Katz, Aaron., J, Chen, Ronald., C, Deborah., S, Danus, Susanne., M, Zullig, Leah., L. 2023. Cardiovascular disease prevention and management of pre-existent cardiovascular disease in a cohort of prostate cancer survivors . Journal of Cancer Survivorship, 17 (2), 351-359.
  • Chen, Ronald., C, Prime, Sabrina., G, Basak, Ramsankar, Moon, Dominic., H, Liang, Claire, Usinger, Deborah., S, Katz, Aaron., J. 2021. Receipt of guideline-recommended surveillance in a population-based cohort of active surveillance prostate cancer patients. International Journal of Radiation Oncology Biology Physics, 110 (3), 712-715
  • Lin, Hsuan., Y, Lin, Fang., J, Katz, Aaron., J, Wang, I., T, Wu, Chung., H. 2022. Antipsychotic use in early pregnancy and the risk of maternal and neonatal complications. Mayo Clinic Proceedings, 97 (11), 2086-2096